Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 62, Issue 5, 2013, Pages 449-457

  Olivotto, Iacopo ^a   Maron, Barry J ^b   Tomberli, Benedetta ^a   Appelbaum, Evan ^c,d   Salton, Carol ^c,d   Haas, Tammy S ^b   Gibson, C Michael ^c,d   Nistri, Stefano ^a   Servettini, Eleonora ^a   Chan, Raymond H ^d   Udelson, James E ^e   Lesser, John R ^b   Cecchi, Franco ^a   Manning, Warren J ^c,d   Maron, Martin S ^e  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

cardiac magnetic resonance; cardiomyopathy; hypertrophic; hypertrophy; obesity; outcome

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GENDER; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBESITY; PATIENT CODING; PHENOTYPE; PRIORITY JOURNAL;

BMI; BODY MASS INDEX; CARDIAC MAGNETIC RESONANCE; CARDIOVASCULAR MAGNETIC RESONANCE; CMR; HAZARD RATIO; HCM; HR; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHY; LATE GADOLINIUM ENHANCEMENT; LEFT VENTRICULAR; LEFT VENTRICULAR HYPERTROPHY; LGE; LV; LVH; NEW YORK HEART ASSOCIATION; NYHA; OBESITY; OUTCOME;

ADULT; BODY MASS INDEX; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTENSION; ITALY; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PHENOTYPE; SEX FACTORS; UNITED STATES; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 84880585514     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.062     Document Type: Article

References (33)

1. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2012 242 255
2. H. Watkins, H. Ashrafian, and C. Redwood Inherited cardiomyopathies N Engl J Med 364 2011 1643 1656
3. B.J. Gersh, B.J. Maron, and R.O. Bonow 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 2703 2738
4. I. Olivotto, F. Girolami, and S. Nistri The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice J Cardiovasc Transl Res 2 2009 349 367
5. I. Olivotto, F. Cecchi, C. Poggesi, and M.H. Yacoub Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging Circ Heart Fail 5 2012 535 546
6. E. Ciró, P.F. Nichols 3rd, and B.J. Maron Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy. Two-dimensional echocardiographic analysis Circulation 67 1983 1227 1233
7. L. Wang, J.G. Seidman, and C.E. Seidman Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy Ann Intern Med 152 2010 513 520 W181
8. E.W. Daw, S.N. Chen, and G. Czernuszewicz Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy Hum Mol Genet 16 2007 2463 2471
9. R. Kahn, R.M. Robertson, R. Smith, and D. Eddy The impact of prevention on reducing the burden of cardiovascular disease Circulation 118 2008 576 585
10. N.I. Parikh, M.J. Pencina, and T.J. Wang Increasing trends in incidence of overweight and obesity over 5 decades Am J Med 120 2007 242 250
11. R.F. Kushner Clinical assessment and management of adult obesity Circulation 126 2012 2870 2877
12. K.M. Flegal, B.K. Kit, H. Orpana, and B.I. Graubard Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis JAMA 309 2013 71 82
13. S.R. Heckbert, W. Post, and G.D. Pearson Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the Multiethnic Study of Atherosclerosis J Am Coll Cardiol 48 2006 2285 2292
14. O.J. Rider, J.M. Francis, and M.K. Ali Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study J Cardiovasc Magn Reson 11 2009 9
15. E.B. Turkbey, R.L. McClelland, and R.A. Kronmal The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA) J Am Coll Cardiol Img 3 2010 266 274
16. National Institutes of Health Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report Obes Res 6 Suppl 2 1998 51S 209S
17. E.D. Abel, S.E. Litwin, and G. Sweeney Cardiac remodeling in obesity Physiol Rev 88 2008 389 419
18. S.C. Smith Jr., E.J. Benjamin, and R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation J Am Coll Cardiol 58 2011 2432 2446
19. M.S. Maron, I. Olivotto, and C. Harrigan Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy Circulation 124 2011 40 47
20. M.S. Maron, I. Olivotto, and A.G. Zenovich Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239
21. I. Olivotto, M.S. Maron, and C. Autore Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 52 2008 559 566
22. S. Piran, P. Liu, A. Morales, and R.E. Hershberger Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure J Am Coll Cardiol 60 2012 283 289
23. P.G. Danias, N.A. Tritos, M. Stuber, K.V. Kissinger, C.J. Salton, and W.J. Manning Cardiac structure and function in the obese: A cardiovascular magnetic resonance imaging study J Cardiovasc Magn Reson 5 2003 431 438
24. C.Y. Wong, T. O'Moore-Sullivan, R. Leano, N. Byrne, E. Beller, and T.H. Marwick Alterations of left ventricular myocardial characteristics associated with obesity Circulation 110 2004 3081 3087
25. B.J. Maron Sudden death in hypertrophic cardiomyopathy J Cardiovasc Transl Res 2 2009 368 380
26. P. Spirito, P. Bellone, K.M. Harris, P. Bernabo, P. Bruzzi, and B.J. Maron Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy N Engl J Med 342 2000 1778 1785
27. I. Olivotto, R. Gistri, P. Petrone, E. Pedemonte, D. Vargiu, and F. Cecchi Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 41 2003 315 321
28. M.S. Maron, I. Olivotto, and S. Betocchi Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
29. S. Kenchaiah, J.C. Evans, and D. Levy Obesity and the risk of heart failure N Engl J Med 347 2002 305 313
30. A. Oreopoulos, R. Padwal, K. Kalantar-Zadeh, G.C. Fonarow, C.M. Norris, and F.A. McAlister Body mass index and mortality in heart failure: a meta-analysis Am Heart J 156 2008 13 22
31. G. Grassi, G. Seravalle, and F. Quarti-Trevano Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms Hypertension 49 2007 535 541
32. R. Clarke Long-term weight loss and prevention of cardiovascular disease Circulation 124 2011 2801 2802
33. N. Tsybouleva, L. Zhang, and S. Chen Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy Circulation 109 2004 1284 1291